selected publications
-
journal article
- Two Classes of Myosin Inhibitors, Para-nitroblebbistatin and Mavacamten, Stabilize β-Cardiac Myosin in Different Structural and Functional States. Journal of Molecular Biology. 2021
- Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties. Journal of Biological Chemistry. 17451-17462. 2019
- Contractility parameters of human β-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function. Science Advances. 2015